According to NIH https://www.nih.gov, pain affects more Americans than diabetes, heart disease, and cancer combined. Understanding the brain pathways that underlie the generation and regulation of pain and emotion is essential to improving outcomes for this large and growing population.
The Cognitive and Affective Neuroscience Lab (CANLab) at the University of Colorado, in Boulder https://canlabweb.colorado.edu is collaborating with cliexa Inc. http://www.cliexa.com, a Denver-based startup. The plans are to develop an interactive mobile technology to provide for a more effective way to treat chronic pain.
CANLab Postdoctoral Researcher, Pavel Goldstein has been working on a project funded jointly by NIH and cliexa. The team was confronted with problems that very often stymie pain studies.
The researchers are developing an electronic platform to allow people suffering from chronic pain to record and track interactions between pain, emotion, and body experiences and deliver this information to researchers and clinicians.
University of Colorado’s, Boulder Technology Transfer Office www.colorado.edu/techtransfer, has enabled CANLab to file a provisional patent for the development of a multidimensional objective pain concept. cliexa’s mobile platform will host CANLab’s research concept and will be used to further develop CANLab’s existing pain studies. The University of Colorado and cliexa anticipate that a novel pain assessment model could be ready for commercialization as early as 2018.